Cited by 723Multiple Sclerosis Research StudiesTryptophan and brain disordersCancer survivorship and care

Depression in multiple sclerosis: a review

Open access
Siegert, R J·2005·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

Several studies have reported high rates of depression in multiple sclerosis (MS) with a lifetime prevalence of approximately 50% and an annual prevalence of 20% not uncommon. Concern about the potential of new drug treatments to exacerbate or precipitate depression in MS has led to increased interest in the relation between MS and depression. This review on MS and depression identifies the following key issues: How common is depression in people with MS? Is depression in MS associated with lesions in specific regions of the central nervous system? Is there an increased risk of suicide in MS? Is there a higher than expected incidence of anxiety disorders in MS? Are fatigue and depressed mood related in MS? Is there a relation between depression and cognitive impairment in MS? Which psychosocial variables affect the development of depression in MS? Does treatment with interferon increase the risk of depression? How effective are treatments for MS patients with depression? Each of these issues is briefly reviewed with critical commentary, and some priorities for future research are suggested.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp.2004.054635

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [8]8. Janssens ACJW, van Doorn PA, de Boer JB, et al. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003;108:389-95.
  2. [77]77. Klapper MD. Letter to the editor [letter]. Neurology 1994;44:188.
  3. [86]86. Mohr DC, Goodkin DE. Treatment of depression in multiple sclerosis. Clin Psychol Sci Pract 1999;6:1-9.

Cited by

Sorted by citations

Authors
Siegert, R. J.
Affiliations
University of Otago (NZ)
Corresponding author
Siegert, R J
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2005-04-01
Volume
76
Issue
4
Pages
469-475
ISSN
0022-3050 (ISSN-L)
OpenAlex
W2144215670
Cited by
718
References
93
Citations by year
2026: 15 · 2025: 11 · 2024: 31 · 2023: 22 · 2022: 44 · 2021: 34 · 2020: 45 · 2019: 39 · 2018: 33 · 2017: 48 · 2016: 48 · 2015: 50 · 2014: 39 · 2013: 35 · 2012: 44
FWCI
3.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
multiple sclerosis, depression, depression prevalence, brain lesions, suicide risk, anxiety disorders, fatigue, cognitive impairment, psychosocial factors, interferon therapy, antidepressant treatment
MeSH terms
Interferon beta-1a, Adjuvants, Immunologic, Anxiety, Central Nervous System, Cognition Disorders, Depression, Fatigue, Humans, Interview, Psychological, Magnetic Resonance Imaging, Multiple Sclerosis, Neuropsychological Tests, Surveys and Questionnaires, Risk Factors, Suicide, Comorbidity, Prevalence, Interferon-beta, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review